Welcome to the 2014 Norwegian Cancer Symposium on the theme “Harnessing innate and adaptive immunity in cancer therapy”. Immunotherapy against cancer is finally coming of age. During the last decade we have witnessed durable clinical responses and even cure of previously incurable diseases, such as chronic lymphocytic leukemia, following distinct immunotherapeutic interventions. An emerging theme […]

Organized by Institute of Clinical Medicine at the University of Oslo. Program: 14:30 IntroductionGuttorm Haraldsen, Department of Pathology and K.G. Jebsen InflammationResearch Centre, University of Oslo (UiO) and OUH. 14:40 Natural killer T-cell activation – inhibition by self lipids.Espen Melum, Norwegian PSC Research Center, OUH. 15:00 Gene discoveries in multiple sclerosis: Novel cues to the […]

Medicon Valley Alliance is pleased to invite you to join our Cancer Immunotherapy Partnering Mission to the U.S. East Coast. Members of the Oslo Cancer Cluster are invited to join. The mission, which is organized by MVA’s Boston-based Ambassador Torsten Jepsen, is a unique opportunity for you to get up to speed on the latest […]

Norsk Biotekforum og  Smerud Medical Research International AS  inviterer til møte i møteserien om klinisk utprøvning.  Registration Program: Kliniske studier innenfor cancer immunterapi  – Introduksjon  v/Knut T. Smerud, Smerud Medical Research International AS Faglig bakgrunn for immunoterapi og oversikt generelt om temaet – Professor Gustav Gaudernack, Oslo Universitetssykehus Bedriftspresentasjoner: o   Ultimovacs AS v/Øyvind Arnesen, CEO […]

R&D Christmas Network: “New insights in immuno-oncology” This meeting is kindly sponsored by the Radium Hospital Foundation (Radiumhospitalets legater). Download program   Moderator: Gunnar Kvalheim, Head of the Department of Cellular Therapy, OUS PROGRAM 14:00–14:15 Registration and coffee 14:15 – 14:20: Funding opportunities -Ole Johan Borge, Innovation Norway 14:20–14:40 Welcome and Update – short introduction– […]

Hva er immunonkologi og hvorfor er det et medisinsk gjennombrudd? Hva betyr dette for klinisk praksis, pasientene og samfunnet? I flere tiår har forskere og leger opparbeidet seg kliniske erfaringer på hvordan man kan påvirke immunforsvaret hos kreftpasienter til å eliminere sykdommen. Dette fagfeltet kalles immunonkologi. Behandlingen baserer seg på å påvirke pasientens eget immunforsvar […]

This is the first seminar in our educational series on cancer immunotherapies featuring: Novel treatment strategies and their clinical implementation in melanoma and beyond. Download PROGRAM here and please REGISTER below. If you for some reason may not attend, please let us know 24 hours prior to the event. Target group: Clinicians. We will limit the […]

Oslo Cancer Cluster will be presenting at this 3rd CIMT Endeavour Workshop on Translating cancer science into products and companies. The Endevaour workshop is a part of the annual CIMT Meeting, which is Europe’s largest immuno-oncology meeting. The concept of CIMT Endeavour is to organize and build-up a unique and focused education and networking platform […]

Seminar of the KG Jebsen Center for Cancer Immunotherapy, co-hosted by Oslo Cancer Cluster   Speaker: Bob Valamehr, Vice President, Cancer Immunotherapy at Fate Therapeutics Inc Moderator: Kalle Malmberg, KG Jebsen Center for Cancer Immunotherapy   Program will be available soon. Here is the invitation: KG Jebsen Seminar_FEb 17th